Literature DB >> 18370482

Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain.

R A Seymour1, P J Kelly, J E Hawkesford.   

Abstract

A double-blind, randomised trial was carried out to investigate the relationship between efficacy and various pharmacokinetic variables after single doses of racemic ketoprofen 12.5 and 25mg in patients with postoperative pain after third molar surgery over a 4-hour investigation period. Serial venous blood samples were obtained at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3 and 4 hours after administration for subsequent determination of R(-) and S(+) ketoprofen. The relationship between the R(-) and S(+) ketoprofen concentrations and pain experience was summarised for each patient by the slope of the regression line for that individual. There was no significant difference (p > 0.05) between the two doses of ketoprofen for any of the efficacy measures. Peak plasma concentrations of both R(-) and S(+) ketoprofen were observed between 60 and 90 minutes after dosage. A significant negative correlation (p < 0.002) was observed between the decrease in pain scores and plasma concentrations of both R(-) and S(+) ketoprofen after each dose. However, the amount of variability in each patient's response makes it difficult to identify a causal relationship between these parameters. Low doses of ketoprofen provide satisfactory pain relief in the early postoperative period after third molar surgery. Efficacy of this analgesic does not appear to be dose related or directly related to plasma concentrations of either R(-) or S(+) enantiomers.

Entities:  

Year:  1998        PMID: 18370482     DOI: 10.2165/00044011-199815040-00003

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  13 in total

1.  Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea.

Authors:  D R Mehlisch
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

Review 2.  Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

Authors:  F Lapicque; N Muller; E Payan; N Dubois; P Netter
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

Review 3.  The use of third molar surgery in clinical pharmacology.

Authors:  J G Meechan; R A Seymour
Journal:  Br J Oral Maxillofac Surg       Date:  1993-12       Impact factor: 1.651

4.  Analgesic methodology: a brief history and commentary.

Authors:  L Lasagna
Journal:  J Clin Pharmacol       Date:  1980 May-Jun       Impact factor: 3.126

5.  The correlation between blood levels of ibuprofen and clinical analgesic response.

Authors:  E M Laska; A Sunshine; I Marrero; N Olson; C Siegel; N McCormick
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

Review 6.  Ketoprofen: a review of its pharmacologic and clinical properties.

Authors:  T G Kantor
Journal:  Pharmacotherapy       Date:  1986 May-Jun       Impact factor: 4.705

7.  Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

8.  Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid.

Authors:  B Bannwarth; F Lapicque; F Pehourcq; P Gillet; T Schaeverbeke; C Laborde; J Dehais; A Gaucher; P Netter
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

9.  Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.

Authors:  B J Cathcart; J D Vince; A J Gordon; M A Bell; I M Chalmers
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

10.  Double-blind parallel comparison of single oral doses of ketoprofen, codeine, and placebo in patients with moderate to severe dental pain.

Authors:  D Mehlisch; L Frakes; M B Cavaliere; M Gelman
Journal:  J Clin Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.126

View more
  3 in total

1.  Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery.

Authors:  F Jamali; C M Kunz-Dober
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Diclofenac and ketoprofen liver toxicity in rat.

Authors:  Zdenko Tomic; Boris Milijasevic; Ana Sabo; Lalosevic Dusan; Vida Jakovljevic; Momir Mikov; Satman Majda; Velibor Vasovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

3.  Ibuprofen and ketoprofen potentiate UVA-induced cell death by a photosensitization process.

Authors:  Emmanuelle Bignon; Marco Marazzi; Vanessa Besancenot; Hugo Gattuso; Guillaume Drouot; Christophe Morell; Leif A Eriksson; Stephanie Grandemange; Elise Dumont; Antonio Monari
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.